Symbotic-horizontal-full-color.png
Symbotic Announces Primary and Secondary Offering of Class A Common Stock
21 févr. 2024 16h00 HE | Symbotic Inc.
Symbotic Announces Primary and Secondary Offering of Class A Common Stock
Angus Gold Logo.png
Angus Gold Announces $4.6 Million Private Placement, Including Investment from Wesdome Gold Mines
19 janv. 2024 10h29 HE | Angus Gold Inc.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, Jan. 19,...
abaxx logo.png
Abaxx Announces Closing of Strategic Financing in Abaxx Singapore
10 janv. 2024 07h00 HE | Abaxx Technologies Inc.
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (NEO:ABXX)(OTCQX:ABXXF)...
BlueberriesMedicalLogo.jpg
Blueberries Medical Announces Closing of C$2 Million Non-Brokered Private Placement
29 déc. 2023 17h00 HE | Blueberries Medical Corp.
TORONTO, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
StayApp-Blue-Horz-Stay.png
Stay Inc. Announces $5 Million USD Offering
07 déc. 2023 08h50 HE | Stay Inc.
STAY INC. ANNOUNCES $5 MILLION USD OFFERING
abaxx logo.png
Abaxx Closes CAD$30.7 Million Financing and Terminates ATM Program
21 nov. 2023 17h25 HE | Abaxx Technologies Inc.
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated April 26, 2023 to its short form base shelf prospectus dated November 4, 2021 ...
Jo-Jo Capital Canada Ltd. Announces Closing of Initial Public Offering
14 nov. 2023 12h57 HE | Jo-Jo Capital Canada Ltd.
NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Jo-Jo Capital Canada Ltd. (the "Corporation") (TSXV:...
Full Logo - OKYO .jpg
OKYO Pharma Announces $5.84 Million Cash Raise and Payables Reduction
31 oct. 2023 07h00 HE | OKYO Pharma LTD
Pricing of a registered direct offering for $1.64M of 1,092,600 ordinary shares at an offering price of $1.50 per ordinary shareSimultaneous extinguishment of $4.20M of payables by issuing 2,766,667...
RAMM logo.jpg
RAMM Pharma Corp. Announces Corporate Update
11 oct. 2023 11h49 HE | RAMM Pharma Corp.
TORONTO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- On September 5th, 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announced its intention to...
Full Logo - OKYO .jpg
OKYO Pharma Announces Closing of $4.0 Million Registered Direct Offering of Ordinary Shares
15 sept. 2023 07h00 HE | OKYO Pharma LTD
LONDON and NEW YORK, Sept. 15, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101...